Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Immunoglobulin-like transcript 2
Email alerts
Immunoglobulin-like transcript 2
Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses
Andrew
Zloza
,
Dae Won
Kim
,
Seunghee
Kim-Schulze
,
Michael C
Jagoda
,
Vladia
Monsurro
,
Francesco M
Marincola
,
Howard L
Kaufman
Journal for ImmunoTherapy of Cancer
Dec 2014,
2
(1)
1;
DOI:
10.1186/2051-1426-2-1
Special collections
COVID-19
(43)
Editor's choice
JITC
Basic Tumor Immunology
(454)
Case Reports
(188)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(801)
Commentary/Editorials
(130)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(43)
Guidelines and Consensus Statements
(39)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(160)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(329)
Liquid Biopsies
(7)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(113)
Reviews
(214)
Open access
(2716)
Press releases
